雷迪帕韦中间体; (1R,3S,4S)-N-叔丁氧羰基-2-氮杂双环[2.2.1]庚烷-3-羧酸; (1R,3S,4S)-N-叔丁氧羰基-2-氮杂双环-[2.2.1]-庚烷-3-羧酸; (1R,3S,4S)-N-Boc-2-氮杂双环[2.2.1]庚烷-3-羧酸
2-Azabicyclo[2.2.1]heptane-2,3-dicarboxylic acid, 2-(1,1-dimethylethyl) ester, (1R,3S,4S)-; (1R,3S,4S)-2-{[(2-Methyl-2-propanyl)oxy]carbonyl}-2-azabicyclo[2.2.1]heptane-3-carboxylic acid; (1R,3S,4S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid; T55 A CNTJ CVOX1&1&1 DVQ &&(1R,3S,4S)- Form; (1R,3S,4S)-2-(tert-butoxycarbonyl)-2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid; Ledipasvir Intermediate-2; (3S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid; (1R,3S,4S)-2-(tert-butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid
室温,干燥密封
PDF: 291775-59-2_ch
PDF: 291775-59-2_en